- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, August 11, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in Forbes referenced a study published in the December 2020 issue of The American Journal of Managed Care® (AJMC®). The study, “Estimating the Economic Burden of Migraine on US Employers,” described the Migraine Impact Model and how it could estimate the prevalence of migraines in the workforce and the economic burden of those migraines on employers.
An article from GeneOnline referenced an article published AJMC’s sister site, The Center for Biosimilars®. The article, “Samsung Bioepis Report Correlates Biosimilar Pricing Changes With Market Adoption,” summarized the first edition of the Samsung Bioepis Biosimilar Market Report, which outlines the current state of the biosimilars market in the United States and how the increasing adoption of biosimilars has affected pricing changes for the medications and their reference products.
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
October 3rd 2025This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Read More
